Term pricing · Provider review
bmiMD tirzepatide review: the cheapest rate is a twelve-month bet
bmiMD sells compounded tirzepatide from $139 a month, and does something almost nobody else does: holds that price at every dose. The catch is that the good rates are prepaid terms, so the number that matters is not what you are billed — it is what you paid for each month you actually used.
Published · Rates as published by bmiMD on that date · Editorial score 8.5 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Two things about bmiMD are genuinely unusual, and they pull in opposite directions.
The first is that the price does not move with your dose. Compounded tirzepatide is titrated upward over months, and at a lot of providers the rate climbs with it — the figure you compared at 2.5mg is not the figure you pay at 10mg. bmiMD says the same price applies at every dose, which converts an advertised rate into something you can actually budget against.
The second is that its best rates require paying six or twelve months up front, before you know whether you tolerate the medication at all. That is the part worth doing arithmetic on.
The short answer
- Best structural feature
- Same price at every dose. It removes the single biggest hidden cost in compounded GLP-1 pricing, and almost nothing else in this vertical commits to it.
- Where most buyers should start
- Three months at $477. Enough runway to get through titration and learn how you respond, without a year of prepaid exposure.
- Biggest risk
- Prepaying twelve months. Stop at month three and the $1,668 you paid works out at $556 for each month you used — worse than the monthly plan.
What each term costs if you finish it
The published ladder, with the full term cost worked out. Every tier includes the provider visit, free shipping on subscription orders and 24/7 clinician access, so these are close to all-in numbers rather than medication-only rates.
| Term | Monthly rate | Cost of the term | Versus buying monthly |
|---|---|---|---|
| 1 month | $179 | $179 | — |
| 3 months | $159 | $477 | saves $60 |
| 6 months | $149 | $894 | saves $180 |
| 12 months | $139 | $1,668 | saves $480 |
Twelve months costs $1,668 against $2,148 bought a month at a time — a $480 saving for committing a year ahead. That is the number bmiMD wants you to look at, and on its own terms it is accurate.
What each term costs if you stop early
Here is the table nobody publishes. A prepaid term does not refund itself when you stop, so the real cost of a plan is the total divided by the months you actually used. Read down a column to see what happens to each tier if treatment ends sooner than planned.
| Term (total paid) | Stop after 1 month | Stop after 3 months | Stop after 6 months | Finish the term |
|---|---|---|---|---|
| 1 month ($179) | $179/mo | — | — | $179/mo |
| 3 months ($477) | $477/mo | $159/mo | — | $159/mo |
| 6 months ($894) | $894/mo | $298/mo | $149/mo | $149/mo |
| 12 months ($1,668) | $1,668/mo | $556/mo | $278/mo | $139/mo |
The twelve-month plan is the cheapest option on the site and the most expensive way to try tirzepatide for a quarter. Three months at $477 is the tier that survives contact with reality: if it works, you step up to a longer term; if it does not, you are out $477 rather than $1,668.
Confirm bmiMD’s cancellation and refund terms directly before choosing a long term — the arithmetic above assumes a prepaid term is not refunded pro rata, which is the normal arrangement but should be checked against the Return & Refund Policy rather than assumed.
What bmiMD publishes about its pharmacy
Compounded medication is only as good as the pharmacy behind it, and most platforms will not say more than “state-licensed.” bmiMD publishes an actual test panel, with tolerances and standards named.
- Potency — confirmed every 3 to 6 months to stay within ±10% of target strength
- Sterility — screened for bacteria, fungi and other contaminants to USP 797 standards
- Endotoxicity — checked to USP 85 limits for bacterial toxins
- pH — adjusted for a smooth, irritation-free injection
- Prepared in a state-licensed pharmacy, independently verified in FDA- and DEA-registered labs
bmiMD adds that compounded medication uses ingredients solely from FDA-licensed sources and that it works exclusively with licensed sterile compounding pharmacies in the United States. None of that makes a compounded product FDA-approved, and bmiMD says as much itself in unusually plain language. It is still more disclosure than the category norm, and specific enough to hold the company to.
On the molecule itself, direct comparative research has associated tirzepatide’s dual GIP and GLP-1 action with greater average weight reduction than semaglutide — which is why it commands a premium nearly everywhere it is sold, and why a flat $139 is competitive.
Strengths and friction
What bmiMD does well
- Same price at every dose — removes the usual hidden cost of titration
- Term pricing published openly, from $179/mo down to $139/mo
- Provider visit included rather than billed separately
- 100% refundable if a provider finds you ineligible
- Publishes a real pharmacy test panel with named standards and tolerances
- Free shipping on every subscription order, plus expedited delivery
- 24/7 clinician access, refills delivered, entirely online
- Candid compliance language about compounded status and FDA review
Where it falls short
- Compounded tirzepatide is not FDA-approved or FDA-evaluated
- Best rates require six or twelve months paid before you know your tolerance
- Countdown-timer urgency applied to pricing that is likely to recur
- No branded Zepbound option for patients who need the approved product
- Tirzepatide only — no semaglutide tier to step down to on price
- The 4.9 rating and 1,000+ review count name no review platform
- Clinical services run through third-party doctor networks
Who it suits
This is for the buyer who has already settled on tirzepatide, accepts compounded medication, and wants a price that will still be true six months in at a higher dose. On those terms bmiMD is one of the better structured offers in this vertical — the flat-dose commitment does more for predictability than any headline discount.
It suits you less if you need the FDA-approved product, since bmiMD does not sell Zepbound and says so. It also suits you less if you are still deciding between molecules, because there is no semaglutide tier here to compare against. And if you want medication inside a broader behaviour-change program, note that the National Institute of Diabetes and Digestive and Kidney Diseases reports these medications work best combined with a lifestyle program, and that regain is likely after stopping — which is also the honest frame for any twelve-month total on this page.
The verdict
Most platforms compete on the entry price and quietly recover margin at the maintenance dose. bmiMD has given that lever up, and publishing its pharmacy tolerances points the same direction: this is a company willing to be specific where specificity can be checked against it later.
The friction is the sales layer. A countdown clock on a seasonal promotion, a 4.9 rating with no platform attached, and the best pricing gated behind a prepaid year all pull against the credibility the rest of the page earns. The compounded status is a real trade-off too, though bmiMD states it more plainly than most of its competitors.
One of the stronger compounded tirzepatide offers on structure rather than headline price. Start at $477 for three months, get the flat-dose pricing confirmed in writing, and extend the term once you know how you tolerate it.
bmiMD: common questions
What does bmiMD tirzepatide cost?
It depends on how long you commit. bmiMD publishes $179/mo month to month, $159/mo on three months (a $477 term), $149/mo on six months ($894) and $139/mo on twelve months ($1,668). Free shipping on every subscription order, 24/7 clinician access and the provider visit are included at every tier.
Is the 12-month plan actually the best value?
Only if you finish it. At $1,668 for twelve months it is $480 a year cheaper than buying monthly, which is real money. But if you stop after three months you have paid $1,668 for three months of treatment — $556 for each month you actually used, which is worse than every other tier including the monthly one. The twelve-month rate is a bet on tolerating the medication, not simply a discount.
Does bmiMD charge more as my dose increases?
No. bmiMD states the same price at every dose. This is the most consequential line on its product page. Compounded tirzepatide is titrated upward over months, and providers that price by dose can cost substantially more at a maintenance dose than their advertised entry rate suggests. A flat rate turns the advertised price into an actual budget.
Is bmiMD tirzepatide FDA-approved?
No. bmiMD offers compounded tirzepatide and states directly that compounded medications offered through it are produced in FDA-registered facilities but are not FDA-approved and have not been evaluated by the FDA for safety, efficacy or quality. Zepbound is the FDA-approved tirzepatide product and bmiMD does not sell it.
What testing does bmiMD publish for its compounded medication?
Four tests, which is more specific than most of this category manages. Potency is confirmed every three to six months to stay within plus or minus 10 percent of target strength. Sterility is screened for bacteria, fungi and other contaminants to USP 797 standards. Endotoxicity is checked to USP 85 limits. pH is adjusted for injection comfort. Medication is described as prepared in a state-licensed pharmacy and independently verified in FDA- and DEA-registered labs.
What if a provider decides I am not eligible?
bmiMD advertises the program as 100% risk free and 100% refundable if you are not eligible. Providers retain full discretion to prescribe or decline, so being turned down is a genuine possible outcome — and bmiMD refunding it is a meaningful difference from platforms whose consultation fees are non-refundable once completed.
Should the countdown timer influence my decision?
No. bmiMD runs a Summer Closeout countdown next to its pricing. Seasonal promotions in this category tend to recur, and a clock is designed to compress the comparison shopping you should be doing. Let the flat-dose pricing and the term you can realistically finish decide it, and ask what your rate becomes once the promotion ends.
Who provides the clinical care at bmiMD?
bmiMD states that the assessment on its site does not create a doctor-patient relationship, and that clinical services are provided by doctor networks of US-licensed clinicians who determine eligibility from your history and responses. bmiMD does not manufacture compounded medication and partners with licensed sterile compounding pharmacies across the United States.
Can I pay with FSA or HSA funds?
bmiMD runs a dedicated FSA/HSA page and addresses the question in its own FAQ. Because term pricing is published up front you can size the draw before committing — $477 for three months or $1,668 for a full year. Buy now, pay later is also offered at checkout.
Keep comparing
See how the rest of the market prices the same medications on the weight loss rankings, or read the head-to-head articles in the comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what bmiMD published on the date above and changes frequently; promotional term rates in particular are time-limited. Term totals and cost-per-month-used figures are calculated from those published monthly rates, assume a prepaid term is not refunded pro rata, and exclude anything billed separately. Confirm the current rate and the cancellation terms before you pay.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by bmiMD, and does not sell treatment. Read our ranking methodology.